Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Leydig-cell tumors of the testicle].
Guerriero O, Pezzullo L, Conzo G, Candela G, Troncone G, Santini L. Guerriero O, et al. Among authors: pezzullo l. Ann Ital Chir. 1990 Nov-Dec;61(6):651-5; discussion 655-6. Ann Ital Chir. 1990. PMID: 2100115 Review. Italian.
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A. Chiappetta G, et al. Among authors: pezzullo l. Eur J Cancer. 2008 May;44(7):1015-21. doi: 10.1016/j.ejca.2008.02.039. Epub 2008 Mar 28. Eur J Cancer. 2008. PMID: 18375116
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.
Chiappetta G, Basile A, Arra C, Califano D, Pasquinelli R, Barbieri A, De Simone V, Rea D, Giudice A, Pezzullo L, De Laurenzi V, Botti G, Losito S, Conforti D, Turco MC. Chiappetta G, et al. Among authors: pezzullo l. J Clin Endocrinol Metab. 2012 Jan;97(1):E115-20. doi: 10.1210/jc.2011-0484. Epub 2011 Nov 9. J Clin Endocrinol Metab. 2012. PMID: 22072743
Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series.
Conzo G, Avenia N, Ansaldo GL, Calò P, De Palma M, Dobrinja C, Docimo G, Gambardella C, Grasso M, Lombardi CP, Pelizzo MR, Pezzolla A, Pezzullo L, Piccoli M, Rosato L, Siciliano G, Spiezia S, Tartaglia E, Tartaglia F, Testini M, Troncone G, Signoriello G. Conzo G, et al. Among authors: pezzullo l. Endocrine. 2017 Feb;55(2):530-538. doi: 10.1007/s12020-016-0953-2. Epub 2016 Apr 13. Endocrine. 2017. PMID: 27075721
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A. Marotta V, et al. Among authors: pezzullo l. Endocr Relat Cancer. 2017 Sep;24(9):485-493. doi: 10.1530/ERC-17-0085. Epub 2017 Jul 10. Endocr Relat Cancer. 2017. PMID: 28696209
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.
Bellevicine C, Migliatico I, Sgariglia R, Nacchio M, Vigliar E, Pisapia P, Iaccarino A, Bruzzese D, Fonderico F, Salvatore D, Biondi B, Masone S, Novizio V, Scavuzzo F, Serino D, De Palma M, Chiofalo MG, Botti G, Pezzullo L, Nuzzo V, Spiezia S, De Chiara G, Iorio S, Conzo G, Docimo G, Faggiano A, Bongiovanni M, Malapelle U, Colao A, Triassi M, Troncone G; Tiroide Network. Bellevicine C, et al. Among authors: pezzullo l. Cancer Cytopathol. 2020 Feb;128(2):107-118. doi: 10.1002/cncy.22217. Epub 2019 Dec 10. Cancer Cytopathol. 2020. PMID: 31821746 Free article.
New molecular targeted therapies in thyroid cancer.
Milano A, Chiofalo MG, Basile M, Salzano de Luna A, Pezzullo L, Caponigro F. Milano A, et al. Among authors: pezzullo l. Anticancer Drugs. 2006 Sep;17(8):869-79. doi: 10.1097/01.cad.0000224449.16329.c5. Anticancer Drugs. 2006. PMID: 16940797 Review.
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.
Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R. Collina F, et al. Among authors: pezzullo l. Cancers (Basel). 2019 Jun 7;11(6):785. doi: 10.3390/cancers11060785. Cancers (Basel). 2019. PMID: 31181609 Free PMC article.
163 results